Literature DB >> 15867831

Asthma in the pediatric sickle cell patient with acute chest syndrome.

Rosalind Bryant1.   

Abstract

INTRODUCTION: Acute chest syndrome (ACS) is a potential life-threatening complication of sickle cell disease (SCD). The purpose of this study was to identify the frequency of asthma in children with SCD who were diagnosed with ACS. The objective was to determine if an increased frequency of asthma exists in children with SCD and ACS.
METHOD: A retrospective descriptive chart review covering the period from June 1997 to June 2002 was conducted on 60 children ranging in age from 1.5 years to 17 years who had SCD and ACS. Cross-tabs analysis and student t tests were used to determine the significance of the occurrence of asthma in children in whom ACS developed.
RESULTS: Of the 60 eligible children with SCD, 53% (32/60) had asthma and/or abnormal pulmonary function tests prior to the development of ACS. DISCUSSION: This is the first study to report a slight increase in the frequency of asthma prior to the initial ACS in children with SCD. The small convenience sample size from one center may have been a limitation in this study to detect significant differences between the variables.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15867831     DOI: 10.1016/j.pedhc.2004.12.003

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  11 in total

Review 1.  Asthma morbidity and treatment in children with sickle cell disease.

Authors:  Samuel O Anim; Robert C Strunk; Michael R DeBaun
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

Review 2.  Pulmonary complications of sickle cell disease.

Authors:  Andrew C Miller; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2012-03-23       Impact factor: 21.405

3.  Elevation of IgE in children with sickle cell disease is associated with doctor diagnosis of asthma and increased morbidity.

Authors:  Ping An; Emily A Barron-Casella; Robert C Strunk; Robert G Hamilton; James F Casella; Michael R DeBaun
Journal:  J Allergy Clin Immunol       Date:  2011-03-09       Impact factor: 10.793

4.  Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease.

Authors:  Nitin Patel; Caryn S Gonsalves; Minyang Yang; Punam Malik; Vijay K Kalra
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

5.  Progression and prognostic indicators of bronchial disease in children with sickle cell disease.

Authors:  Sophia N Williams; Eliezer Nussbaum; Leila Yoonessi; Tricia Morphew; Inderpal Randhawa
Journal:  Lung       Date:  2014-04-04       Impact factor: 2.584

Review 6.  How I treat hypoxia in adults with hemoglobinopathies and hemolytic disorders.

Authors:  Evans M Machogu; Roberto F Machado
Journal:  Blood       Date:  2018-09-11       Impact factor: 22.113

7.  Asthma in sickle cell disease: implications for treatment.

Authors:  Kathryn Blake; John Lima
Journal:  Anemia       Date:  2011-03-03

8.  Arginase and arginine dysregulation in asthma.

Authors:  Renée C Benson; Karen A Hardy; Claudia R Morris
Journal:  J Allergy (Cairo)       Date:  2011-04-26

Review 9.  Acute Chest Syndrome in Children with Sickle Cell Disease.

Authors:  Shilpa Jain; Nitya Bakshi; Lakshmanan Krishnamurti
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2017-12-01       Impact factor: 1.349

Review 10.  Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.

Authors:  Claudia R Morris; Mark T Gladwin; Gregory J Kato
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.